Switzerland
CVC-backed Sunrise lists in €3.06bn IPO
IPO is the largest in Switzerland since 2006, with €3.06bn market cap
SHS backs AOT
Growing market for robot-guided surgical systems prompts investment
Equistone divests avocis to Capita for €210m
Capita to use acquisition to grow its business in DACH region
Unigestion’s Engler joins Axon
Placement agent appoints Mark Engler as partner in its Zug office
Akina closes Euro Choice Secondary on €224m
Fund launched in Q4 2013 with €200m target
DACH region suffers activity slump in 2014
DACH deal volume has dropped to its lowest position since 2002
CVC-backed Sunrise plans CHF 1.35bn IPO
Greenshoe option would increase IPO by 15% if exercised in full
Adveq promotes four to executive director
Fund-of-funds manager Adveq announces promotions
Auctus closes fourth fund on €230m
Latest vehicle oversubscribed in less than three months
NeoMed leads CHF 20m Genkyotex financing
VI Partners and BioMedInvest are co-investors
SPFS acquires APEN portfolio for $192m
APEN also sells entire loan obligation and deleverages
Apax sells Orange Switzerland to NJJ for €2.3bn
Sale comes after three-year holding period
Versant closes fund on $305m, makes European promotions
Principal Tom Woiwode has been promoted to managing director in firm's Basel office
Rive buys Parquest’s 5aSèc
Shareholders have injected €10m fresh equity into company
Wenger to step down as COO of Partners Group
Announcement part of wider reshuffle in the firm's management structure
Onex acquires SIG Combibloc for €3.75bn
Private equity house will pay $1.25bn in equity with commitments from co-investors and SIG's management
Zurmont Madison sells CLS for $77m
Exit comes after five-year holding period
Parter Capital injects CHF 4.5m into Histide
Private equity house specialises in research-based investments
Montana closes second fund on $100m
Montana Annual Secondary Program II closes on hard-cap after three months
Molecular floats with CHF 482m market cap
Shares dropped to CHF 22.4 within hours, having opened on CHF 25
Bayer commits $25m to Versant's fifth fund
Bayer and Versant had already worked together on drug discovery incubator
Molecular Partners to raise CHF 96m after IPO delay
Offering will give company a market cap of CHF 485m
Akina holds interim close for Euro Choice Secondary
Fund will hold final close on 17 December
Gilde acquires Riri from Synergo
Synergo divests Switzerland-headquartered zipper & button manufacturer